Joyce Obidi, Gayathri Sridhar, Graça M Dores, Barbee Whitaker, Carlos H Villa, Emily Storch, Kinnera Chada, Lisa M Schilling, Karthik Natarajan, Paul Biondich, Andrey Soares, Matthew Spotnitz, Thomas Falconer, Saptarshi Purkayastha, Nicole L Draper, Hui-Lee Wong, Matthew Stagg, Christian Reich, Steven Anderson, Azadeh Shoaibi
BACKGROUND: Current hemovigilance methods generally rely on survey data or administrative claims data utilizing billing and revenue codes, each of which has limitations. We used electronic health records (EHR) linked to blood bank data to comprehensively characterize red blood cell (RBC) utilization patterns and trends in three healthcare systems participating in the U.S. Food and Drug Administration Center for Biologics Evaluation and Research Biologics Effectiveness and Safety (BEST) initiative...
April 30, 2024: Transfusion